BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications.Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn's Disease.

Biotechnology

BiomeBank

BiomeBank's headquarters in Adelaide, Australia

Sam Costello

Description

People (8)

Sam Costello

Johnathon Matthews

Paul Flynn FUniSA, MAICD, FFIA

Sarah Haylock-Jacobs

Philippa C.

Galina Murina

Isiri Perera

Christopher Waterman

Jobs